- Open Access
Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection
Journal of Cardiovascular Magnetic Resonance volume 12, Article number: 18 (2010)
In the situation of acute coronary occlusion, the myocardium supplied by the occluded vessel is subject to ischemia and is referred to as the myocardium at risk (MaR). Single photon emission computed tomography has previously been used for quantitative assessment of the MaR. It is, however, associated with considerable logistic challenges for employment in clinical routine. Recently, T2-weighted cardiovascular magnetic resonance (CMR) has been introduced as a new method for assessing MaR several days after the acute event. Furthermore, it has been suggested that the endocardial extent of infarction as assessed by late gadolinium enhanced (LGE) CMR can also be used to quantify the MaR. Hence, we sought to assess the ability of endocardial extent of infarction by LGE CMR to predict MaR as compared to T2-weighted imaging.
Thirty-seven patients with early reperfused first-time ST-segment elevation myocardial infarction underwent CMR imaging within the first week after percutaneous coronary intervention. The ability of endocardial extent of infarction by LGE CMR to assess MaR was evaluated using T2-weighted imaging as the reference method.
MaR determined with T2-weighted imaging (34 ± 10%) was significantly higher (p < 0.001) compared to the MaR determined with endocardial extent of infarction (23 ± 12%). There was a weak correlation between the two methods (r2 = 0.17, p = 0.002) with a bias of -11 ± 12%. Myocardial salvage determined with T2-weighted imaging (58 ± 22%) was significantly higher (p < 0.001) compared to myocardial salvage determined with endocardial extent of infarction (45 ± 23%). No MaR could be determined by endocardial extent of infarction in two patients with aborted myocardial infarction.
This study demonstrated that the endocardial extent of infarction as assessed by LGE CMR underestimates MaR in comparison to T2-weighted imaging, especially in patients with early reperfusion and aborted myocardial infarction.
The myocardium at risk (MaR), defined as the hypoperfused myocardium during acute coronary occlusion will be subject to infarction if no reperfusion occurs. The ability to assess MaR in relation to the final infarct size enables determination of myocardial salvage and, consequently, the efficacy of reperfusion therapy in patients with acute coronary occlusion [2, 3].
Currently, the most widely used method to determine myocardial perfusion defects is myocardial perfusion single photon emission computed tomography (SPECT). This technique can be used to assess MaR in the acute setting by intravenously injecting a perfusion tracer during coronary occlusion [4, 5]. However, this approach has limitations in the clinical setting since the patient needs to have the perfusion tracer injected prior to reperfusion and undergo imaging in a gamma camera within approximately 3 hours. Thus, using myocardial perfusion SPECT for determination of MaR in patients with acute coronary occlusion is a major logistic challenge not possible at many hospitals. Hence, there is a need for more clinically feasible methods to assess MaR that can be performed after the acute revascularization.
T2-weighted cardiovascular magnetic resonance (CMR) has recently been introduced as a method for quantification of MaR, and has been validated in both animals and humans. Furthermore, it has recently been suggested that the endocardial extent of infarction as assessed by late gadolinium enhanced (LGE) CMR can be used to determine MaR [9, 10]. The pathophysiological basis for using endocardial extent of infarction as a measure of MaR is that previous experimental studies have shown that the endocardial extent of infarction is established approximately 40 minutes after coronary occlusion. Thereafter, the infarcted area will increase by transmural progression from the endocardium to the epicardium with increasing duration of ischemia, referred to as the wavefront phenomenon. Thus, time to reperfusion is thought to limit the transmural infarct progression rather than the endocardial extent of infarction. This implicates that the endocardial extent of infarction could potentially be used for assessing the MaR after acute coronary occlusion. However, in the situation of early reperfusion, infarction might be completely or almost completely aborted [12, 13], resulting in difficulties when assessing MaR based on infarct characteristics.
Therefore, we sought to assess the ability of endocardial extent of infarction assessed by LGE CMR to predict MaR as compared to T2-weighted imaging in patients with first-time early reperfused myocardial infarction.
Study population and design
The study was approved by the local ethics committee and all patients gave their written informed consent. Thirty-seven patients (age; 62 ± 10, 32 males) with first-time myocardial infarction, presenting with acute ST-elevation myocardial infarction (STEMI), due to a single occluded coronary artery as seen by angiography, were included in the study. Patients with a non-occluded culprit artery, contraindications for CMR such as metal implants, signs of an old infarction were excluded. All patients were treated by primary percutaneous coronary intervention (PCI) with coronary stenting, resulting in TIMI grade 3 flow in the culprit artery. CMR was performed within the first week after PCI in all patients.
CMR was performed on either of two 1.5-T systems: Magnetom Vision (Siemens, Erlangen, Germany) with a CP body array coil, or Philips Intera CV (Philips, Best, the Netherlands) with a cardiac synergy coil. All subjects were placed in supine position and images were acquired at end-expiratory breath hold with electrocardiographic gating. Initial scout images were acquired to locate the heart, and a T2-weighted triple inversion turbo spin echo sequence was employed to depict the myocardium at risk. T2-weighted images were acquired in the short-axis view, covering the left ventricle from base to apex. Imaging parameters for the T2-weighted sequence were: echo time, 43 ms (Siemens), or 100 ms (Philips); repetition time, 2 heart beats; number of averages, 2; inversion time, 180 ms; image resolution, 1.5 × 1.5 mm; slice thickness, 10 mm (Siemens), or 8 mm with a slice gap of 2 mm (Philips). When acquiring images with the cardiac synergy coil, parallel imaging with SENSE = 1 was used to minimize signal inhomogeneities due to differences in coil sensitivity.
Long- and short-axis late gadolinium enhanced (LGE) images covering the entire left ventricle were then acquired approximately 20 minutes after intravenous administration of 0.2 mmol/kg extracellular gadolinium-based contrast agent (gadoteric acid; Guerbet, Gothia Medical AB, Billdal, Sweden). The LGE images were acquired with an inversion-recovery sequence with following imaging parameters; slice thickness 10 mm, field of view 380 mm, matrix 126 × 256, flip angle 25°, repetition time 100 ms, echo time 4.8 ms (Siemens) or slice thickness 8 mm, field of view 340 mm, repetition time 3.14 ms, echo time 1.58 ms (Philips). Inversion time was adjusted to null the signal from viable myocardium.
All CMR images were analyzed using the freely available software Segment v1.8 http://segment.heiberg.se . The T2-weighted MaR was identified according to a previously described methodology. In short, in all short-axis slices, the hyperintense regions were delineated manually by independent and blinded observers after manual tracing of the endocardial and epicardial borders of the left ventricle. The papillary muscles were excluded from the myocardium. The MaR was then defined as the total amount of hyperintense myocardium in all short-axis slices and expressed as percentage of left ventricular myocardium. If present, an area of hypointense signal within the area of increased signal intensity was included in the MaR.
The infarcted myocardium was automatically quantified from the short-axis LGE images according to a previously described method. In short, the endocardial and epicardial borders were traced manually with exclusion of the papillary muscles. The LGE myocardium was then defined using a computer algorithm that takes into consideration partial volume effects within the infarcted region. Manual adjustments were made when the computer algorithm was obviously wrong. If present, a hypointense signal within the area of LGE (microvascular obstruction) was included in the analysis as being completely infarcted. Finally, myocardial infarct size was expressed as percent of left ventricular myocardium.
The myocardium at risk by endocardial extent of infarction was determined in each short-axis slice by measuring the circumferential distance between the lateral borders of the LGE region (Figure 1). The lateral borders of LGE were used since the mid-mural LGE might extent beyond the endocardial circumferential edges. The endocardial extent of MI was then defined as the sum of the LGE endocardial circumferential distance in each short-axis slice, divided by the total endocardial extent of the LV.
Myocardial salvage was defined as 100*([MaR - infarct size]/MaR), where MaR was assessed by both T2-weighted imaging and endocardial extent of infarction.
Continuous variables are presented as mean ± SD. Pearson's correlation was used to determine the relationship between MaR assessed by T2-weighted imaging and endocardial extent of infarction. The agreement between T2-weigthed imaging and endocardial extent of infarction was expressed as mean difference ± SD, and the limits of agreement were shown in a Bland-Altman graph as mean ± 2 SD. The difference between using T2-weighted imaging and endocardial extent of infarction for determination of MaR to derive myocardial salvage, was assessed by a paired t-test. SPSS version 17.0 software package (Chicago, Illinois, USA) was used for analysis. A value of p below 0.05 was considered statistically significant.
The characteristics of the 37 patients included in this study are presented in Table 1. In 59% (22/37) of all patients, the left anterior descending coronary artery was the culprit vessel and in 35% (13/37) of the patients, the right coronary artery was the culprit vessel. All patients underwent CMR imaging within seven days (mean 4 ± 3 days) after percutaneous coronary intervention.
Myocardium at risk
A region with increased signal intensity by T2-weighted imaging was observed in all patients, resulting in a myocardium at risk of 34 ± 10% (range 18 - 59) of the left ventricular (LV) myocardium. The endocardial extent of infarction was 23 ± 12% (range 0 - 66) of the total LV endocardial surface.
Figure 2A shows a scatter plot indicating the relationship between T2-weighted imaging and endocardial extent of infarction. There was a weak correlation between the two methods (r2 = 0.17, p = 0.002). Figure 2B shows the limits of agreement between endocardial extent of infarction and T2-weighted imaging, demonstrating an underestimation of the myocardium at risk by endocardial extent of infarction (mean difference -11 ± 12%). Two patients showed no signs of infarction by LGE CMR and two patients showed > 90% salvage (encircled in Figure 2A and Figure 2B). All four patients had, however, an occluded artery on angiography, ST-elevation indicative of transmural ischemia and biomarker release indicative of myocyte necrosis. Myocardium at risk in these four patients measured 36 - 46% by T2-weighted imaging and 0 - 8% by endocardial extent of infarction.
Figure 3 shows three examples of the agreement of MaR by T2-weighted imaging and endocardial extent of infarction by LGE CMR.
There was no statistical significant correlation between MaR measured by T2-weighted imaging or endocardial extent of infarction and time from pain onset to reperfusion (Table 2).
The infarct size by LGE CMR was 14 ± 10% (range 0 - 47) of the LV myocardium. In comparison to the MaR by T2-weighted imaging, the infarct size was smaller in all patients (p = 0.002) (Figure 4A). For one patient the MI size was greater than the MaR as assessed by endocardial extent of infarction (Figure 4B).
The infarct size significantly correlated with peak CK-MB and peak Troponin T. There was, however, no correlation between infarct size and time from pain onset to reperfusion (Table 2).
Comparison of the infarct size by LGE CMR with the MaR by T2-weighted imaging and endocardial extent of infarction yielded a myocardial salvage of 58 ± 22% (range 13 - 100) and 45 ± 23% (range -7 - 100), respectively (Figure 5). Thus, myocardial salvage assessed by T2-weighted imaging was significantly higher than when assessed with endocardial extent of infarction (p < 0.001).
There was not a significant correlation between myocardial salvage, measured by T2-weighted imaging and endocardial extent of infarction, and time from pain onset to reperfusion (Table 2).
This study shows that endocardial extent of infarction as assessed by LGE CMR underestimated the myocardium at risk in comparison to T2-weighted imaging in patients undergoing early reperfusion therapy of first-time myocardial infarction.
In the experimental setting, it has been shown that approximately 40 minutes after coronary occlusion the extent of endocardial necrosis is established and remains equal up to 8 weeks after the acute coronary occlusion [11, 16]. When the endocardial extent is established, the infarction will progress from the endocardium to the epicardium as the duration of ischemia increases. This is often referred to as the wavefront phenomenon. Thus, time to reperfusion is thought to limit the transmural infarct progression rather than the endocardial extent of the infarct.
In the present study, the endocardial extent of infarction significantly underestimated the MaR compared to T2-weighted imaging. This is in accordance with recent findings by Wright et al, where a difference between the two methods was found in patients where pronounced myocardial salvage or infarct abortion was achieved with acute reperfusion therapy. Some patients in the present study showed no signs of infarction by LGE CMR but did, however, show evidence of ischemic myocardium by T2-weighted imaging, as was also seen by Wright et al. The correlation between endocardial extent of infarction and MaR by T2-weighted imaging was, however, significantly weaker in the present study compared to their study (r2 = 0.17 vs r2 = 0.59). This difference may be due to fewer patients and a limited range of MaR by T2-weighted imaging in the present study.
When using endocardial extent of infarction for the assessment of MaR, several aspects need to be considered. Following acute coronary occlusion, myocytes swell due to failure of energy-regulated membrane channels, resulting in intracellular influx of water and sodium. If ischemia persists, the cell membrane will disintegrate, which is the onset of necrosis, resulting in increased distribution volume for the gadolinium-based contrast agent used for infarct visualization. Recently, Cury et al have shown that an increased signal on T2-weighted images can be found in the absence of LGE in patients presenting with clinical signs of acute coronary syndrome. Furthermore, Abdel-Aty et al found that there was an apparent change in signal intensity on the T2-weighted images at a mean of 28 minutes after coronary occlusion in dogs. However, despite an increased signal on the T2-weighted images present after approximately 30 minutes, no LGE was found in the ischemic myocardium. Thus, if early reperfusion is accomplished in the situation of acute coronary occlusion, there might be an absence of LGE on the CMR images, referred to as aborted infarction [12, 13]. Consequently, LGE CMR imaging does not allow for determination of MaR in this situation, whereas T2-weighted imaging does. The present study showed a significant difference between T2-weighted imaging and endocardial extent of infarction for the quantification of MaR. This can in part be explained by the presence of an aborted infarction. The current study had two patients with an aborted infarction and two patients with a myocardial salvage of more than 90% of the initial myocardium at risk as assessed by T2-weighted imaging. In these four patients, the MaR was 36 - 46% of the LV as assessed by T2-weighted imaging and 0 - 8% as assessed by endocardial extent of infarction, affecting the determination of myocardial salvage in the patients significantly.
In an experimental setting, Fieno et al showed that the endocardial extent of infarction might change over time after infarction as assessed by LGE CMR. Furthermore, Engblom et al recently showed, in a human population, that the endocardial extent of LGE significantly decreased during the first week after coronary occlusion. This was explained by a possible decrease in LGE of a viable peri-infarction zone that surrounded the irreversibly injured core of myocytes in the early post-infarction period. This reduction of endocardial LGE implicates a difference in MaR between day one and week one when assessed by CMR. Thus, the endocardial extent of infarction as measured with LGE CMR may change within the first week after coronary occlusion due to initial enhancement of the peri-infarction zone not present at one week. Myocardium at risk by T2-weighted imaging, however, does not change during the first week after infarction.
T2-weighted imaging has been shown to enable distinction between acute and chronic myocardial infarction. Hence, MaR can potentially be assessed even in the presence of old infarction. Presence of old infarction, however, disables determination of MaR using endocardial extent of infarction by LGE CMR.
Another situation where MaR assessed by endocardial extent of infarction might be misleading is in the case of periprocedural induction of MI, which has been reported to occur in approximately 6% of all patients with non-STEMI undergoing acute reperfusion therapy. A significant myocardial salvage might be missed if MaR is based on the endocardial extent of a small transmural PCI-induced infarct caused by distal embolization of a small coronary branch.
In the present study, no significant correlation was found between myocardial salvage and time from pain onset to reperfusion. The relationship between myocardial salvage and duration of ischemia in humans has recently been described in a study by Hedström et al. The inclusion and exclusion criteria in the present study differ significantly from those applied by Hedström et al. For example, patients with biomarker release prior to PCI were excluded in the latter. The present study, however, included a more general population presenting with clinical signs of acute myocardial infarction. Thus, some patients in the present study had biomarker release prior to PCI, which may be an indicator of spontaneous reperfusion and re-occlusion that has been shown to sometimes occur in the early phase of acute coronary thrombosis. As a consequence, the duration of persistent ischemia may be overestimated in these patients, affecting the relationship between myocardial salvage and duration of ischemia assessed in the present study.
The present study was performed on a patient population presenting with first-time STEMI and undergoing successful reperfusion therapy. Thus, the applicability of the current results to settings like non-reperfused acute MI remains illusive. Furthermore, since only five women were included in the study the results cannot be generalized to both genders.
No independent measure of MaR, such as myocardial perfusion single photon emission computed tomography (SPECT) was obtained in the present study. Previous studies, however, have shown that T2-weighted imaging agrees well with myocardial perfusion SPECT [3, 8].
Image quality can be a limitation in assessing MaR by T2-weighted imaging, and the image quality of the T2-weighted images used in the present study did not allow for automatic segmentation.
This study demonstrated that the endocardial extent of infarction as assessed by LGE CMR underestimates the myocardium at risk in comparison to T2-weighted imaging, especially in patients with early reperfusion and aborted myocardial infarction.
Cardiovascular Magnetic Resonance
Late Gadolinium Enhanced
Myocardium at Risk
ST-Elevation Myocardial Infarction
Single Photon Emission Computed Tomography
Thrombolysis in Myocardial Infarction.
Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E: Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation. 1998, 97: 1848-1867.
Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R: The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008, 51: 1581-1587. 10.1016/j.jacc.2008.01.019.
Hedstrom E, Engblom H, Frogner F, Astrom-Olsson K, Ohlin H, Jovinge S, Arheden H: Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage. J Cardiovasc Magn Reson. 2009, 11: 38-10.1186/1532-429X-11-38.
Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA: Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 1990, 82: 1424-1437.
Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, Chesebro JH, Wackers FJ: Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation. 1989, 80: 1277-1286.
Pennell D: Myocardial salvage: retrospection, resolution, and radio waves. Circulation. 2006, 113: 1821-1823. 10.1161/CIRCULATIONAHA.105.618942.
Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF, Arai AE: Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006, 13: 1865-70. 10.1161/CIRCULATIONAHA.105.576025.
Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H: Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009, 2: 569-576. 10.1016/j.jcmg.2008.11.018.
Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ, Bonow RO, Wu E: Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J. 2007, 28: 1750-1758. 10.1093/eurheartj/ehm212.
Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J: Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging. 2009, 2: 825-831. 10.1016/j.jcmg.2009.02.011.
Reimer KA, Lowe JE, Rasmussen MM, Jennings RB: The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977, 56: 786-794.
Lamfers EJ, Hooghoudt TE, Hertzberger DP, Schut A, Stolwijk PW, Verheugt FW: Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart. 2003, 89: 496-501. 10.1136/heart.89.5.496.
Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M: Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. Jama. 1993, 270: 1211-6. 10.1001/jama.270.10.1211.
Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM: An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001, 218: 215-223.
Heiberg E, Ugander M, Engblom H, Gotberg M, Olivecrona GK, Erlinge D, Arheden H: Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology. 2008, 246: 581-588. 10.1148/radiol.2461062164.
Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS, Parker MA, Klocke FJ, Kim RJ, Judd RM: Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol. 2004, 43: 2124-2131. 10.1016/j.jacc.2004.01.043.
Willerson JT, Scales F, Mukherjee A, Platt M, Templeton GH, Fink GS, Buja LM: Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977, 87: 159-188.
Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rat. Radiology. 1999, 211: 698-708.
Cury RC, Shash K, Nagurney JT, Rosito G, Shapiro MD, Nomura CH, Abbara S, Bamberg F, Ferencik M, Schmidt EJ, Brown DF, Hoffmann U, Brady TJ: Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation. 2008, 118: 837-844. 10.1161/CIRCULATIONAHA.107.740597.
Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG: Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol. 2009, 53: 1194-201. 10.1016/j.jacc.2008.10.065.
Engblom H, Hedstrom E, Heiberg E, Wagner G, Pahlm O, Arheden H: Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: One-year follow-up by MRI. Circulation Cardiovascular Imaging. 2009, 2: 47-55. 10.1161/CIRCIMAGING.108.802199.
Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R, Friedrich MG: Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004, 109: 2411-2416. 10.1161/01.CIR.0000127428.10985.C6.
Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW: Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009, 54: 477-486. 10.1016/j.jacc.2009.03.063.
Hackett D, Davies G, Chierchia S, Maseri A: Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987, 317: 1055-1059.
The authors would like to acknowledge Ann-Helen Arvidsson and Christel Carlander, both with the Lund Cardiac MR Group, for their skillful assistance with image acquisition. This study has been funded by the Swedish Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty at Lund University, Sweden, and Region of Scania, Sweden.
The authors declare that they have no competing interests.
JU, HE, and HA were involved in the study concept. JU, HE, EH, MC and HA were involved in the study design. DE, SJ, EH and MC performed data acquisition, JU, HE and HA were involved in data analysis/interpretation. JU, HE, DE, SJ, EH, MC and HA were involved in either manuscript preparation or editing. All authors read and approved the final manuscript.
About this article
- Single Photon Emission Compute Tomography
- Percutaneous Coronary Intervention
- Cardiovascular Magnetic Resonance
- Infarct Size
- Myocardial Perfusion Single Photon Emission Compute Tomography